chapter six
medications. A standardized preparation of Pygeum africanum may be a useful treatment option, at least in the short term, for men with lower urinary symptoms consistent with benign prostatic hyperplasia.”
II. Ongoing Clinical Research
Different databases were used to identify the ongoing research studies related to benign prostatic hyperplasia( BPH). A total of 353 studies were found when the condition“ benign prostatic hyperplasia” was searched and below is a summary of the findings:
1. Research on Saw Palmetto Extract in Benign Prostatic Hyperplasia The study compared 160 mg twice a day of the herbal extract versus an identical placebo among men who had discontinued all other medications to treat BPH. The participants were seen in a clinic every 3 months for 1 year. The primary factor observed was a change in the American Urological Association Symptom Index score. The study results were reported in the New England Journal of Medicine in February 2006. The authors concluded that in this study saw palmetto did not improve symptoms or objective measures of benign prostatic hyperplasia.
2. Research Study on Serenoa repens on Inflammation Biomarkers in Urinary Symptoms Related to BPH( Benign Prostatic Hyperplasia) The study compared a lipidosterolic extract of Serenoa repens( saw palmetto) with a prescription medication for 90 days. The primary factors observed were changes from the baseline in urine and serum inflammation biomarkers. No study results were posted and no links to publications were provided.
3. Research on the Efficacy of a Natural Extract Combined with Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto The study compared the oral administration of one capsule containing a combination of 250 mg of a natural extract and 160 mg of saw palmetto lipidic extract plus inactive fillers twice a day between meals to
38